Observational Study of the Switch of Metformin Alone to Metformin Combined With Repaglinide in Type 2 Diabetes
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe.
The aim of this observational study is to investigate the switch from metformin alone to
metformin combined with repaglinide in type 2 diabetic patients not achieving adequate
glycaemic control on maximal dose of metformin given alone and to analyse different
epidemiological parameters.